Here’s what you should know:
1. Perceptive Advisors led the financing round, serving as the exclusive investor.
2. Landos is a pharmaceutical pipeline developing treatments for autoimmune diseases, specifically for Crohn’s disease and ulcerative colitis.
3. The funding will be used to advance the development of BT-11, specifically to advance the product through its initial phase I clinical testing.
More articles on gastroenterology:
GI leader to know: Dr. Daryl M. McClendon of Alaska Digestive and Liver Disease Clinic
12 statistics on gastroenterologist salary — $357k is median
Penn State College of Medicine taps Dr. Thomas Ma for chairmanship — 4 key notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.